Clinical trials
Recruiting Lymphoma trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 7 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione Italiana Linfomi - ETS | 4 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 3 |
| Nurix Therapeutics, Inc. | 2 |
| AstraZeneca | 1 |
| Azienda USL Reggio Emilia - IRCCS | 1 |
| Curis, Inc. | 1 |
| Dren Bio | 1 |
| Hoffmann-La Roche | 1 |
| Iksuda Therapeutics Ltd. | 1 |
| Incyte Biosciences International Sàrl | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 25 |
| Lymphoma, Follicular | 5 |
| Neoplasms | 5 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Recurrence | 4 |
| Hodgkin Disease | 3 |
| Immune System Diseases | 3 |
| Leukemia | 3 |
| Lymphoma, Mantle-Cell | 3 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.